Keywords: york, pharma, carbenoxolone, performs, well, study, uk-based

York Pharma's Carbenoxolone performs well in study

Article | 06 February 2006

UK-based York Pharma, a specialist developer of products for the dermatology market, says that its lead development candidate, carbenoxolone (YP003), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Aquasol A

Vitamin A

Go to drug listing